Due to its hereditary nature, genomic data is not only linked to its owner but to that of close relatives as well. As a result, its sensitivity does not really degrade over time; in fact, the relevance of a genomic sequence is likely to be longer than the security provided by encryption. This prompts the need for specialized techniques providing long-term security for genomic data, yet the only available tool for this purpose is GenoGuard (, 2015). By relying on Honey Encryption, GenoGuard is secure against an adversary that can brute force all possible keys; i.e., whenever an attacker tries to decrypt using an incorrect password, she will obtain an incorrect but plausible looking decoy sequence. In this paper, we set to analyze the real-world security guarantees provided by GenoGuard; specifically, assess how much more information does access to a ciphertext encrypted using GenoGuard yield, compared to one that was not. Overall, we find that, if the adversary has access to side information in the form of partial information from the target sequence, the use of GenoGuard does appreciably increase her power in determining the rest of the sequence. We show that, in the case of a sequence encrypted using an easily guessable (low-entropy) password, the adversary is able to rule out most decoy sequences, and obtain the target sequence with just 2.5 of it available as side information. In the case of a harder-to-guess (high-entropy) password, we show that the adversary still obtains, on average, better accuracy in guessing the rest of the target sequences than using state-of-the-art genomic sequence inference methods, obtaining up to 15 improvement in accuracy.
Recent advances in DNA sequencing technologies have put ubiquitous availability of fully sequenced human genomes within reach. It is no longer hard to imagine the day when everyone will have the means to obtain and store one's own DNA sequence. Widespread and affordable availability of fully sequenced genomes immediately opens up important opportunities in a number of health-related fields. In particular, common genomic applications and tests performed in vitro today will soon be conducted computationally, using digitized genomes. New applications will be developed as genome-enabled medicine becomes increasingly preventive and personalized. However, this progress also prompts significant privacy challenges associated with potential loss, theft, or misuse of genomic data. In this paper, we begin to address genomic privacy by focusing on three important applications: Paternity Tests, Personalized Medicine, and Genetic Compatibility Tests. After carefully analyzing these applications and their privacy requirements, we propose a set of efficient techniques based on private set operations. This allows us to implement in in silico some operations that are currently performed via in vitro methods, in a secure fashion. Experimental results demonstrate that proposed techniques are both feasible and practical today. In this paper, we propose privacy-enhancing technologies for medical tests and personalized medicine methods that use patients' genomic data. Focusing on genetic disease-susceptibility tests, we develop a new architecture (between the patient and the medical unit) and propose a "privacy-preserving disease susceptibility test" (PDS) by using homomorphic encryption and proxy re-encryption. Assuming the whole genome sequencing to be done by a certified institution, we propose to store patients' genomic data encrypted by their public keys at a "storage and processing unit" (SPU). Our proposed solution lets the medical unit retrieve the encrypted genomic data from the SPU and process it for medical tests and personalized medicine methods, while preserving the privacy of patients' genomic data. We also quantify the genomic privacy of a patient (from the medical unit's point of view) and show how a patient's genomic privacy decreases with the genetic tests he undergoes due to (i) the nature of the genetic test, and (ii) the characteristics of the genomic data. Furthermore, we show how basic policies and obfuscation methods help to keep the genomic privacy of a patient at a high level. We also implement and show, via a complexity analysis, the practicality of PDS.  Motivated by privacy and usability requirements in various scenarios where existing cryptographic tools (like secure multi-party computation and functional encryption) are not adequate, we introduce a new cryptographic tool called Controlled Functional Encryption (C-FE). As in functional encryption, C-FE allows a user (client) to learn only certain functions of encrypted data, using keys obtained from an authority. However, we allow (and require) the client to send a fresh key request to the authority every time it wants to evaluate a function on a ciphertext. We obtain efficient solutions by carefully combining CCA2 secure public-key encryption (or rerandomizable RCCA secure public-key encryption, depending on the nature of security desired) with Yao's garbled circuit. Our main contributions in this work include developing and for- mally defining the notion of C-FE; designing theoretical and practical constructions of C-FE schemes achieving these definitions for specific and general classes of functions; and evaluating the performance of our constructions on various application scenarios.